Related Experiment Video
Updated: Aug 7, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
Prevention of early-onset group B streptococcal disease: another look at single-dose penicillin at birth
1Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, USA.
Insights
Single-dose penicillin at birth significantly reduced early-onset group B streptococcal (GBS) invasive disease in newborns. This safe and effective intervention demonstrates the value of universal prophylaxis for GBS prevention.
Area of Science:
- Neonatal Infectious Diseases
- Pediatric Infectious Diseases
- Antibiotic Prophylaxis
Background:
- Group B Streptococcus (GBS) remains a significant cause of neonatal invasive disease.
- Early-onset GBS disease presents a critical public health challenge, particularly in inner-city populations.
- Effective preventive strategies are essential to reduce neonatal morbidity and mortality associated with GBS.
Purpose of the Study:
- To evaluate the impact of a single prophylactic dose of penicillin administered at birth on the incidence of early-onset GBS invasive disease.
- To assess the efficacy of penicillin prophylaxis in a large, diverse inner-city population over an extended period.
- To determine the safety and effectiveness of universal penicillin administration for GBS prevention in newborns.
Main Methods:
- Retrospective analysis of laboratory-based surveillance data for GBS disease from 1972-1994.
- Inclusion of 259,049 live births from Parkland Memorial Hospital, Dallas, Texas.
- Comparison of early-onset GBS disease rates across five distinct observation periods with varying penicillin prophylaxis strategies.
Main Results:
- Penicillin prophylaxis groups demonstrated significantly lower rates of early-onset GBS disease (0.25 and 0.63 per 1,000) compared to untreated groups (1.59, 1.19, and 1.95 per 1,000).
- Penicillin prophylaxis did not affect the incidence of late-onset GBS disease.
- No increase in penicillin-resistant pathogens or associated mortality was observed in infants receiving penicillin.
Conclusions:
- Universal administration of a single dose of penicillin at birth is a safe and highly effective method for preventing early-onset GBS disease.
- This intervention offers a significant public health benefit by reducing neonatal GBS infections.
- The findings support the widespread implementation of penicillin prophylaxis for GBS prevention in newborns.
Objective:
To determine the effect of single-dose penicillin given at birth on the rate of early-onset group B streptococcal (GBS) invasive disease in an inner-city population.
Methods:
Laboratory-based surveillance of GBS disease from 1972-1994 at Parkland Memorial Hospital and Children's Medical Center in Dallas, Texas, was reviewed retrospectively. All infants born at Parkland Memorial Hospital from January 1, 1972 to December 31, 1994, or a total of 259,049 live births, were included. Early-onset (within 3 days) GBS disease rates were compared for each of five observation groups to determine the efficacy of a single dose of aqueous penicillin G 50,000 U for infants weighing 2,000 g or more and 25,000 U for those weighing less than 2,000 g) administered intramuscularly within 1 hour of delivery for prevention of GBS disease.
Results:
The rates of early-onset GBS disease were compared in five observation groups: A) pre-study, January 1, 1972 to December 3, 1977--no GBS prophylaxis; B) prospective, controlled intervention study, December 4, 1977 to May 31, 1981, including infants who received a single dose of penicillin at birth (group B1) and those who did not (group B2); C) universal penicillin prophylaxis, June 1, 1981 to October 31, 1986; and D) no routine penicillin prophylaxis, November 1, 1986 to December 31, 1994. The incidence of early-onset GBS disease in the penicillin groups (B1, C) was significantly lower than that in the untreated groups (A, B2, D): 0.25 and 0.63 per 1,000 versus 1.59, 1.19, and 1.95 per 1,000, respectively (P < or = .03). The incidence of late-onset GBS disease was unaffected by penicillin prophylaxis, and there was no increase in the incidence of disease caused by penicillin-resistant pathogens or associated mortality in penicillin-treated infants; 2.2 and 2.1 per 1,000 versus 1.6 and 3.3 per 1,000 for disease; 1.0 and 0.5 per 1,000 versus 0.4 and 0.3 per 1,000 for deaths.
Conclusion:
Universal administration of single-dose penicillin at birth is a safe and effective intervention for the prevention of early-onset GBS disease.
Related Concept Videos
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Rheumatic Heart Disease III: Medical Management
Production of Antibiotics
Development of the Oral Microbiota
Streptococcal Pharyngitis
Smallpox

